Cargando…
Blockade of Serotonin 5-HT(6) Receptor Constitutive Activity Alleviates Cognitive Deficits in a Preclinical Model of Neurofibromatosis Type 1
Neurofibromatosis type 1 (NF1) is a common inherited disorder caused by mutations of the NF1 gene that encodes the Ras-GTPase activating protein neurofibromin, leading to overactivation of Ras-dependent signaling pathways such as the mTOR pathway. It is often characterized by a broad range of cognit...
Autores principales: | Doucet, Emilie, Grychowska, Katarzyna, Zajdel, Pawel, Bockaert, Joël, Marin, Philippe, Bécamel, Carine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467191/ https://www.ncbi.nlm.nih.gov/pubmed/34576341 http://dx.doi.org/10.3390/ijms221810178 |
Ejemplares similares
-
Early 5‐HT
(6) receptor blockade prevents symptom onset in a model of adolescent cannabis abuse
por: Berthoux, Coralie, et al.
Publicado: (2020) -
Early 5‐HT(6)
receptor blockade prevents symptom onset in a model of adolescent cannabis abuse
por: Berthoux, Coralie, et al.
Publicado: (2022) -
Novel and atypical pathways for serotonin signaling
por: Bockaert, Joël, et al.
Publicado: (2021) -
Superiority of the Triple-Acting 5-HT(6)R/5-HT(3)R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT(6)R Antagonist Intepirdine
in Alleviation of Cognitive Deficits in Rats
por: Grychowska, Katarzyna, et al.
Publicado: (2023) -
Quantitative Phosphoproteomics Unravels Biased Phosphorylation of Serotonin 2A Receptor at Ser(280) by Hallucinogenic versus Nonhallucinogenic Agonists
por: Karaki, Samah, et al.
Publicado: (2014)